Skip to content
POM-V Prescription Required

Equioxx 8.2 mg/g Oral Paste for Horses

Active ingredient: Firocoxib

Form

Paste

Species

Horses

Manufacturer

AUDEVARD

VMD MA No.

44684/5002

What it's used for

Alleviation of pain and inflammation associated with osteoarthritis and reduction of associated lameness in horses.

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Firocoxib

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Equioxx 8.2 mg/g Oral Paste for Horses — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

Alleviation of pain and inflammation associated with osteoarthritis and reduction of
associated lameness in horses.
Oral use.
Administer 0.1 mg firocoxib per kg bodyweight, once daily. Duration of treatment will
be dependent on the response observed, but should not exceed 14 days.
To administer EQUIOXX at the dose of 0.1 mg firocoxib/kg, set the syringe plunger to
the appropriate dose division for the horse’s weight. Each full dose division on the
syringe plunger delivers sufficient firocoxib to treat 100 kg body weight. The contents
of one syringe will treat horses weighing up to 600 kg. To ensure correct dosage,
bodyweight should be determined as accurately as possible to avoid overdosing.
To deliver firocoxib at the appropriate dosage, unlock the knurled ring on the syringe
plunger by rotating it ¼ turn and slide it along the plunger shaft to the appropriate dose
division for the horse’s weight. Rotate the plunger ring ¼ turn to lock it in place and
ensure it is locked.
Make sure the horse’s mouth contains no feed. Remove the cover from the tip of the
syringe. Insert the syringe tip into the horse’s mouth at the interdental space and
deposit the paste on the base of the tongue.
Do not use in animals suffering from gastrointestinal disorders and haemorrhage,
impaired hepatic, cardiac or renal function and bleeding disorders.
Do not use in breeding, pregnant or lactating animals (see section 4.7).
Do not use concomitantly with corticosteroids or other non-steroidal anti-inflammatory
drugs (NSAIDs) (see section 4.8).
Do not use in case of hypersensitivity to the active substance or to any of the excipients.
Lesions (erosion/ulceration) of the oral mucosa and of the skin around the mouth were
very commonly observed in treated animals during tolerance studies. These lesions
were mild and resolved without treatment. Salivation and labial and tongue oedema
have been uncommonly associated with the oral lesions in a field study.
The frequency of adverse reactions is defined using the following convention:
-
-
-
-
-
treated)
None.

Issued: March 2022
AN: 02783/2021

Special precautions for use in animals
Do not use in animals less than 10 weeks. If side effects occur, treatment should be
discontinued and the advice of a veterinarian should be sought. Avoid use in any
dehydrated, hypovolaemic or hypotensive animal, as there may be potential risk of
increased renal toxicity. Concurrent administration of potentially nephrotoxic veterinary
medicinal products should be avoided.
The recommended treatment dose and duration should not be exceeded.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
In case of accidental ingestion, seek medical advice immediately and show the
package leaflet or the label to the physician.
Avoid contact with eyes and skin. If it occurs, rinse affected area immediately with
water. Wash hands after use of the veterinary medicinal product.
Like other medicinal products that inhibit COX-2, pregnant women or women
attempting to conceive should avoid contact with, or wear disposable gloves, when
administering the veterinary medicinal product.
Other NSAIDs, diuretic and substances with high protein binding may compete for

Issued: March 2022
AN: 02783/2021
binding and lead to toxic effects. Do not use concomitantly with corticosteroids or other
NSAIDs.
Pre-treatment with other anti-inflammatory substances may result in additional or
increased adverse effects and a treatment-free period with such medicinal products
should therefore be observed. The treatment-free period should take into account the
pharmacological properties of the medicinal products used previously.
Concomitant treatment with molecules displaying action on renal flow (e.g. diuretics)
should be subject to clinical monitoring. Concurrent administration of potentially
nephrotoxic medicinal products should be avoided as there might be an increased risk
of renal toxicity.
Replace cap after use.
This veterinary medicinal product does not require any special storage conditions.
Meat and offal: 26 days.
Not authorized for use in animals producing milk for human consumption.
5.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.